Authorised distributor ofEyerising International

The Eyerising Myopia Management Device

A compact home device, prescribed by eye professionals

A non-invasive, home-use medical device for myopia control in children aged 3 to 16. It is available only through optometrists and ophthalmologists.

Money Back Guarantee650 nmVisible red light3 minPer session0.29 mWThrough a 4 mm pupil
650 nmVisible red light
3 minPer session
0.29 mWThrough a 4 mm pupil
3–16Years of age

A complete solution

01

The device

Compact and portable, with a child-friendly touchscreen guide and automatic session logging.

02

Online monitoring

Clinicians see compliance, session data and safety reports for each patient, from anywhere.

03

Support

Training for clinic teams, onboarding for families and local technical support from IHCC.

The Eyerising Myopia Management Device

Key specifications

01Therapy
Repeated low-level red light (RLRL)
02Wavelength
650 nm visible red light
03Output
0.29 mW through a 4 mm pupil
04Session
3 minutes
05Schedule
2 sessions a day, at least 4 hours apart, 5 days a week
06Age range
3 to 16 years
07Use
At home, under clinical supervision
08Controls
Touchscreen with guided sessions
09Connectivity
Wi-Fi or 4G, sessions synced to the online system

Designed for children

On the desk at home
01On the desk at home
A session in progress
02A session in progress
Monitored by parents
03Monitored by parents
The guided start screen
04The guided start screen

Safety and supervision

  • Treatment starts only after a full eye examination and a prescription.
  • Regular follow-ups check visual acuity, axial length and retinal health.
  • A minimum of 4 hours between sessions is built into the device.
  • Stop treatment and contact the eye-care professional if there is any discomfort or change in vision.

Regulatory status

Registered in more than 40 markets, including Saudi Arabia, the UAE, the EU, the UK and Australia, and manufactured under an ISO 13485:2016 quality system.

  • SFDA MDMA-2-2025-3726Saudi Arabia
  • ARTG 412752Australia
  • ISO 13485:2016Certified manufacturing
  • 40+ countriesRegulatory approvals

Results vary between children. Treatment must be prescribed and monitored by an eye-care professional.

Offer RLRL therapy at your clinic

Talk to IHCC about partnership, training and a demo device.